cover of episode Biomarker Selection for Maintenance Therapy in Advanced NSCLC

Biomarker Selection for Maintenance Therapy in Advanced NSCLC

2011/9/29
logo of podcast Journal of Clinical Oncology (JCO) Podcast

Journal of Clinical Oncology (JCO) Podcast

Frequently requested episodes will be transcribed first

Shownotes Transcript

EGFR mutation is a predictive biomarker for maintenance erlotinib but its clinical application is limited. This podcast will explain why.